S&P 500   4,546.12 (-0.09%)
DOW   35,358.58 (+0.07%)
QQQ   388.73 (-0.11%)
AAPL   190.12 (+0.17%)
MSFT   380.98 (+0.63%)
META   335.75 (+0.31%)
GOOGL   135.98 (-0.32%)
AMZN   146.45 (-0.87%)
TSLA   236.14 (+0.03%)
NVDA   476.49 (-1.23%)
NIO   7.07 (-1.67%)
BABA   75.59 (-2.50%)
AMD   121.10 (-1.26%)
T   16.13 (-0.49%)
F   10.30 (-0.39%)
MU   74.18 (-4.30%)
CGC   0.53 (-3.76%)
GE   119.54 (-0.36%)
DIS   94.20 (-1.02%)
AMC   6.59 (-3.09%)
PFE   29.90 (-0.80%)
PYPL   56.76 (+0.66%)
XOM   104.07 (+0.11%)
S&P 500   4,546.12 (-0.09%)
DOW   35,358.58 (+0.07%)
QQQ   388.73 (-0.11%)
AAPL   190.12 (+0.17%)
MSFT   380.98 (+0.63%)
META   335.75 (+0.31%)
GOOGL   135.98 (-0.32%)
AMZN   146.45 (-0.87%)
TSLA   236.14 (+0.03%)
NVDA   476.49 (-1.23%)
NIO   7.07 (-1.67%)
BABA   75.59 (-2.50%)
AMD   121.10 (-1.26%)
T   16.13 (-0.49%)
F   10.30 (-0.39%)
MU   74.18 (-4.30%)
CGC   0.53 (-3.76%)
GE   119.54 (-0.36%)
DIS   94.20 (-1.02%)
AMC   6.59 (-3.09%)
PFE   29.90 (-0.80%)
PYPL   56.76 (+0.66%)
XOM   104.07 (+0.11%)
S&P 500   4,546.12 (-0.09%)
DOW   35,358.58 (+0.07%)
QQQ   388.73 (-0.11%)
AAPL   190.12 (+0.17%)
MSFT   380.98 (+0.63%)
META   335.75 (+0.31%)
GOOGL   135.98 (-0.32%)
AMZN   146.45 (-0.87%)
TSLA   236.14 (+0.03%)
NVDA   476.49 (-1.23%)
NIO   7.07 (-1.67%)
BABA   75.59 (-2.50%)
AMD   121.10 (-1.26%)
T   16.13 (-0.49%)
F   10.30 (-0.39%)
MU   74.18 (-4.30%)
CGC   0.53 (-3.76%)
GE   119.54 (-0.36%)
DIS   94.20 (-1.02%)
AMC   6.59 (-3.09%)
PFE   29.90 (-0.80%)
PYPL   56.76 (+0.66%)
XOM   104.07 (+0.11%)
S&P 500   4,546.12 (-0.09%)
DOW   35,358.58 (+0.07%)
QQQ   388.73 (-0.11%)
AAPL   190.12 (+0.17%)
MSFT   380.98 (+0.63%)
META   335.75 (+0.31%)
GOOGL   135.98 (-0.32%)
AMZN   146.45 (-0.87%)
TSLA   236.14 (+0.03%)
NVDA   476.49 (-1.23%)
NIO   7.07 (-1.67%)
BABA   75.59 (-2.50%)
AMD   121.10 (-1.26%)
T   16.13 (-0.49%)
F   10.30 (-0.39%)
MU   74.18 (-4.30%)
CGC   0.53 (-3.76%)
GE   119.54 (-0.36%)
DIS   94.20 (-1.02%)
AMC   6.59 (-3.09%)
PFE   29.90 (-0.80%)
PYPL   56.76 (+0.66%)
XOM   104.07 (+0.11%)

Shockwave Medical Stock Price, News & Analysis (NASDAQ:SWAV)

$168.04
-2.35 (-1.38%)
(As of 10:16 AM ET)
Compare
Today's Range
$167.17
$170.00
50-Day Range
$160.99
$215.69
52-Week Range
$157.00
$315.95
Volume
60,709 shs
Average Volume
577,412 shs
Market Capitalization
$6.20 billion
P/E Ratio
26.17
Dividend Yield
N/A
Price Target
$269.78

Shockwave Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
58.3% Upside
$269.78 Price Target
Short Interest
Healthy
4.39% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.14mentions of Shockwave Medical in the last 14 days
Based on 14 Articles This Week
Insider Trading
Selling Shares
$8.37 M Sold Last Quarter
Proj. Earnings Growth
24.86%
From $3.62 to $4.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.34 out of 5 stars

Medical Sector

7th out of 935 stocks

Surgical & Medical Instruments Industry

3rd out of 95 stocks


SWAV stock logo

About Shockwave Medical Stock (NASDAQ:SWAV)

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Stock Price History

SWAV Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
ShockWave Medical Inc SWAV
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Shockwave Medical: Buying The Dip
Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$269.78
High Stock Price Target
$315.00
Low Stock Price Target
$218.00
Potential Upside/Downside
+60.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$216 million
Pretax Margin
24.35%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$5.87 per share
Book Value
$14.15 per share

Miscellaneous

Free Float
35,643,000
Market Cap
$6.20 billion
Optionable
Not Optionable
Beta
1.01
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives















SWAV Stock Analysis - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price target for 2024?

10 analysts have issued 1 year price objectives for Shockwave Medical's stock. Their SWAV share price targets range from $218.00 to $315.00. On average, they expect the company's stock price to reach $269.78 in the next year. This suggests a possible upside of 58.3% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 at the beginning of the year. Since then, SWAV stock has decreased by 17.1% and is now trading at $170.39.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) announced its earnings results on Monday, November, 6th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.81 by $0.11. The company earned $186.02 million during the quarter, compared to the consensus estimate of $184.71 million. Shockwave Medical had a trailing twelve-month return on equity of 42.41% and a net margin of 36.33%. The firm's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter last year, the business posted $0.92 earnings per share.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by many different institutional and retail investors. Top institutional investors include FMR LLC (6.85%), Artisan Partners Limited Partnership (3.80%), Invesco Ltd. (1.92%), Allspring Global Investments Holdings LLC (1.76%), Morgan Stanley (1.17%) and Canada Pension Plan Investment Board (1.05%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SWAV) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -